Cao, L., Wen, Q., Liu, B., Zhao, Z., Zhang, X., Xu, L., . . . Mo, X. (2024). Plerixafor-based mobilization and mononuclear cell counts in graft increased the risk of engraftment syndrome after autologous hematopoietic stem cell transplantation. Blood Science, 6(3), e00190. https://doi.org/10.1097/BS9.0000000000000190
Chicago Style (17th ed.) CitationCao, Le-Qing, et al. "Plerixafor-based Mobilization and Mononuclear Cell Counts in Graft Increased the Risk of Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation." Blood Science 6, no. 3 (2024): e00190. https://doi.org/10.1097/BS9.0000000000000190.
MLA (9th ed.) CitationCao, Le-Qing, et al. "Plerixafor-based Mobilization and Mononuclear Cell Counts in Graft Increased the Risk of Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation." Blood Science, vol. 6, no. 3, 2024, p. e00190, https://doi.org/10.1097/BS9.0000000000000190.